EOPYY contracted private doctor
(The National Organization for Health Care Services)
Advanced Imaging Technology
- Ultrasound nuchal translucency (Certified by Fetal Medicine Foundation of London)
In humans, there are 23 types of chromosomes and most people have a pair of each one of these chromosomes (therefore a total of 46 chromosomes). In trisomy, there are three rather than two of a particular chromosome (total of 47 chromosomes).
The most common trisomies are those of chromosomes 21, 18 and 13. Trisomy 21 is found in about 1 in 700 births and the risk increases with maternal age. The condition is associated with intellectual disabilities and some physical defects and most commonly heart abnormalities. The life expectancy is about 60 years. Trisomies 18 and 13 are found in about 1 in 7,000 births and the risk increases with maternal age. The conditions are associated with severe mental handicap and several physical defects. Most affected individuals die before or soon after birth and they rarely survive beyond the first year of life.
Today we assess the risks of Down’s syndrome and other chromosomal abnormalities. Each woman will be given an estimate of her individual risk for this pregnancy. This is calculated by taking into account the age of the mother, measurement of two hormones in the mother’s blood and the scan findings of nuchal translucency thickness, nasal bone , and blood flow through the tricuspid valve of the fetal heart and ductus venosus and fetal abnormalities. In the Greek version you can find a video by You tube of the nuchal scan. Parents will receive full counseling concerning the significance of these risks and the various options for further investigations including invasive testing or the cfDNA test.
In addition the aim of the nuchal scan is:
- To date the pregnancy accurately. This is particularly relevant for women who cannot recall the date of their last period, have an irregular menstrual cycle, or who have conceived whilst breastfeeding or soon after stopping the pill. We measure the size of the fetus and from this we calculate the expected date of delivery.
- To diagnose multiple pregnancy. Approximately 2% of natural conceptions and 10% of assisted conceptions result in multiple pregnancy. Ultrasound scanning can determine if both babies are developing normally and if the babies share the same placenta which can lead to problems in the pregnancy. In such cases it would be advisable to monitor the pregnancy more closely.
- To diagnose major fetal abnormalities. Some major abnormalities may be visible at this gestation. However it will still be necessary to have a 20 week anomaly scan.
- To diagnose early miscarriage. Unfortunately, in 2% of women who attend for a nuchal scan it is found that the fetus has died, often several weeks before and without any warning. Couples will receive full counseling as to the possible causes of this problem and the options for subsequent measures that may be necessary.
- To estimate the probability of early pre-clampsia, intrauterine retardation of the fetus, and spontaneous premature birth (FMF certified).
2. Ultrasound nuchal translucency(Certified by Fetal Medicine Foundation of London)
The anatomical scan (18-23 weeks) aims to assess the fetal anatomy the growth, the amount of amniotic fluid and the position of the placenta. On the basis of this scan is offered a thorough counseling on the prevalence, the etiology, the management and the prognosis for both common and rare fetal abnormalities.Read More
Doppler assessment of the fetal circulation plays an important role in assessment of the fetal condition in pathological pregnancies. With this scan we assess the flow of the blood in the main arteries and veins of the fetus.
4. 4D fetus ultrasound scan
The 4D ultrasound scan offers a real time view of the fetus, highlighting the external characteristics of the fetus, so that the diagnosis of anatomical abnormalities of the fetus takes place or is confirmed.
Furthermore, it offers to the parents the opportunity to see the first characteristics of the face of the fetus.
Invasive and non invasive prenatal diagnosis
- Non Invasive Prenatal Testing (NIPT)
- Maternal Serum Screening
- Genetic tests (molecular, biochemical , cytogenetics) in collaboration with ATG Genome
- Fetal cardiac monitoring
Monitoring of low and high risk of pregnancy (diabetes mellitus, control – prevention of premature labor, hypertension, thyroid disorders, maternal thrombophilic disorders, multiple pregnancies, etc.)
Genetic counseling, in collaboration with a clinical geneticist and a specific geneticist dysmorphologist, for: fetal abnormalities, infants, children, hereditary diseases, special breed diseases, family history counseling, blood affinity, exposure to teratogenic substances, unexplained miscarriages, mental retardation, autism etc.
- Check-up (gynecological examination, Pap test, transvaginal ultrasound, breast examination)
- Three-dimensional ultrasound examination of uterus and ovarian (uterine anatomical abnormalities, ovarian cysts, fibroids, etc.)
- Sono-hysterography (uterine endometrial polyps, fibroids, abnormal bleeding)
- Procedures without anesthesia (Pipelle endometrial biopsy, insertion IUD, etc.)
- Colposcopy, cervical biopsies
- Prevention of gynecological cancer
Subfertility- Services of assisted reproduction
- Subfertility- Services of assisted reproduction
- Investigation of the infertile couple
- Induction of ovulation
- Intrauterine insemination
- Application protocols of assisted reproduction, egg and sperm donation, and embryos cryoreserved for natural or surrogate mothers